Results 81 to 90 of about 587 (136)

DETERMINATION OF MELDONIUM, γ-BUTYROBETAINE, AND CARNITINE IN BLOOD PLASMA BY HIGH-PERFORMANCE LIQUID CHROMATOGRAPHY WITH MASS-SELECTIVE DETECTION

open access: yesРазработка и регистрация лекарственных средств, 2019
A procedure for simultaneous quantitative determination of meldonium, L-carnitine, and γ-butyrobetaine in blood plasma by high-performance liquid chromatography with mass-selective detection and the isotopically labeled d9L-carnitine as internal standard
P. N. Sorokoumov   +4 more
doaj  

Use of meldonium in the combination treatment of patients with heart failure in the early post-infarction period

open access: yesТерапевтический архив, 2014
AIM: To evaluate the impact of 10-14-day intravenous administration of meldonium as part of combination therapy in patients with chronic heart failure in the early post-infarction period on the recovery period, structural and functional parameters, and ...
M E Statsenko, N N Shilina, S V Turkina
doaj  

Role of pFox inhibitors in the treatment of patients with acute myocardial ischemia

open access: yesТерапевтический архив, 2014
AIM: To evaluate the anti-ischemic and anti-anginal efficacy of meldonium (Idrinol) in its short-term use as part of combination therapy in patients with chronic heart failure in the early post-infarction period/MATERIAL AND METHODS: The investigation ...
M E Statsenko, S V Turkina, N N Shilina
doaj  

Meldonium Inhibits Cell Motility and Wound-Healing in Trabecular Meshwork Cells and Scleral Fibroblasts: Possible Applications in Glaucoma. [PDF]

open access: yesPharmaceuticals (Basel), 2023
Minnelli C   +9 more
europepmc   +1 more source

The Effects of a Meldonium Pre-Treatment on the Course of the LPS-Induced Sepsis in Rats. [PDF]

open access: yesInt J Mol Sci, 2022
Đurašević S   +12 more
europepmc   +1 more source

Impact myocardial cytoprotection and inotropic stimulation at the annual prognosis in patients with myocardial infarction lifting segment ST, complicated heart failure

open access: yesКардиоСоматика, 2015
The article analyzes the effectiveness and safety of treatment cytoprotectant meldonium dihydrate and inotropic stimulator of levosimendan on an annual prognosis in patients with myocardial infarction complicated by acute heart failure II-III class ...
M. N Sinkova   +5 more
doaj  

Mildronate (meldonium): First, do no harm

open access: yes
Meldonium (Mildronate) is used as a cardioprotective drug; however, it has not been officially approved anywhere outside the former Soviet Union (SU). The supposed action mechanism is based on the carnitine (Lcarnitine) lowering effect in muscular and ...
Jargin S.V.
core  

Blocking L-carnitine synthesis by meldonium prolongs the survival in mice with pancreatic cancer. [PDF]

open access: yesiScience
Sano M   +15 more
europepmc   +1 more source

Home - About - Disclaimer - Privacy